151 related articles for article (PubMed ID: 34692382)
1. Developing Non-Laboratory Cardiovascular Risk Assessment Charts and Validating Laboratory and Non-Laboratory-Based Models.
Hassannejad R; Mansourian M; Marateb H; Mohebian MR; Gaziano TA; Jackson RT; Angelantonio ED; Sarrafzadegan N
Glob Heart; 2021; 16(1):58. PubMed ID: 34692382
[TBL] [Abstract][Full Text] [Related]
2. PARS risk charts: A 10-year study of risk assessment for cardiovascular diseases in Eastern Mediterranean Region.
Sarrafzadegan N; Hassannejad R; Marateb HR; Talaei M; Sadeghi M; Roohafza HR; Masoudkabir F; Oveisgharan S; Mansourian M; Mohebian MR; Mañanas MA
PLoS One; 2017; 12(12):e0189389. PubMed ID: 29261727
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of a Risk Prediction Model for Atherosclerotic Cardiovascular Disease in Japanese Adults: The Hisayama Study.
Honda T; Chen S; Hata J; Yoshida D; Hirakawa Y; Furuta Y; Shibata M; Sakata S; Kitazono T; Ninomiya T
J Atheroscler Thromb; 2022 Mar; 29(3):345-361. PubMed ID: 33487620
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Five-Year Cardiovascular Disease Risk in People with Type 2 Diabetes Mellitus: Derivation in Nanjing, China and External Validation in Scotland, UK.
Wan C; Read S; Wu H; Lu S; Zhang X; Wild SH; Liu Y
Glob Heart; 2022; 17(1):46. PubMed ID: 36051323
[TBL] [Abstract][Full Text] [Related]
5. WHO cardiovascular disease risk prediction model performance in 10 regions, China.
Yang S; Ding Y; Yu C; Guo Y; Pang Y; Sun D; Pei P; Yang L; Chen Y; Du H; Schmidt D; Stevens R; Bennett D; Clarke R; Chen J; Chen Z; Li L; Lv J;
Bull World Health Organ; 2023 Apr; 101(4):238-247. PubMed ID: 37008262
[TBL] [Abstract][Full Text] [Related]
6. Comparison of laboratory-based and non-laboratory-based WHO cardiovascular disease risk charts: a population-based study.
Rezaei F; Seif M; Gandomkar A; Fattahi MR; Malekzadeh F; Sepanlou SG; Hasanzadeh J
J Transl Med; 2022 Mar; 20(1):133. PubMed ID: 35296342
[TBL] [Abstract][Full Text] [Related]
7. External validation of the QLifetime cardiovascular risk prediction tool: population cohort study.
Livingstone S; Morales DR; Fleuriot J; Donnan PT; Guthrie B
BMC Cardiovasc Disord; 2023 Apr; 23(1):194. PubMed ID: 37061672
[TBL] [Abstract][Full Text] [Related]
8. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort.
Gaziano TA; Young CR; Fitzmaurice G; Atwood S; Gaziano JM
Lancet; 2008 Mar; 371(9616):923-31. PubMed ID: 18342687
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of modified risk prediction models for cardiovascular disease and its subtypes: The Hisayama Study.
Honda T; Yoshida D; Hata J; Hirakawa Y; Ishida Y; Shibata M; Sakata S; Kitazono T; Ninomiya T
Atherosclerosis; 2018 Dec; 279():38-44. PubMed ID: 30408715
[TBL] [Abstract][Full Text] [Related]
10. An office-based cardiovascular prediction model developed and validated in cohort studies of a middle-income country.
Fahimfar N; Malekzadeh R; Fotouhi A; Mansournia MA; Sarrafzadegan N; Azizi F; Sepanlou SG; Mansourian M; Hadaegh F; Emamian MH; Poustchi H; Talaei M; Pourshams A; Roohafza H; Sharafkhah M; Samavat T; Lotfaliany M; Steyerberg EW; Khalili D
J Clin Epidemiol; 2022 Jun; 146():1-11. PubMed ID: 34920114
[TBL] [Abstract][Full Text] [Related]
11. Laboratory and non-laboratory-based risk prediction models for secondary prevention of cardiovascular disease: the LIPID study.
Cui J; Forbes A; Kirby A; Simes J; Tonkin A
Eur J Cardiovasc Prev Rehabil; 2009 Dec; 16(6):660-8. PubMed ID: 19738473
[TBL] [Abstract][Full Text] [Related]
12. Predictive Performance of Cardiovascular Disease Risk Prediction Algorithms in People Living With HIV.
van Zoest RA; Law M; Sabin CA; Vaartjes I; van der Valk M; Arends JE; Reiss P; Wit FW
J Acquir Immune Defic Syndr; 2019 Aug; 81(5):562-571. PubMed ID: 31045648
[TBL] [Abstract][Full Text] [Related]
13. Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort study.
Wan EYF; Fong DYT; Fung CSC; Yu EYT; Chin WY; Chan AKC; Lam CLK
Diabetes Obes Metab; 2018 Feb; 20(2):309-318. PubMed ID: 28722290
[TBL] [Abstract][Full Text] [Related]
14. External validation and clinical usefulness of three commonly used cardiovascular risk prediction scores in an Emirati population: a retrospective longitudinal cohort study.
Al-Shamsi S; Govender RD; King J
BMJ Open; 2020 Oct; 10(10):e040680. PubMed ID: 33115904
[TBL] [Abstract][Full Text] [Related]
15. Model for assessing cardiovascular risk in a Korean population.
Park GM; Han S; Kim SH; Jo MW; Her SH; Lee JB; Lee MS; Kim HC; Ahn JM; Lee SW; Kim YH; Kim BJ; Koh JM; Kim HK; Choe J; Park SW; Park SJ
Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):944-51. PubMed ID: 25351481
[TBL] [Abstract][Full Text] [Related]
16. Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart.
Chen L; Tonkin AM; Moon L; Mitchell P; Dobson A; Giles G; Hobbs M; Phillips PJ; Shaw JE; Simmons D; Simons LA; Fitzgerald AP; De Backer G; De Bacquer D
Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):562-70. PubMed ID: 19741542
[TBL] [Abstract][Full Text] [Related]
17. Risk prediction model for gastric cancer within 5 years in healthy Korean adults.
Oh H; Cho S; Lee JA; Ryu S; Chang Y
Gastric Cancer; 2024 Jul; 27(4):675-683. PubMed ID: 38561527
[TBL] [Abstract][Full Text] [Related]
18. Performance of the SCORE and Globorisk cardiovascular risk prediction models: a prospective cohort study in Dutch general practice.
Schoofs MC; Akkermans RP; de Grauw WJ; Schalk BW; van Dis I; Tjin-A-Ton J; Bischoff EW; Biermans MC
Br J Gen Pract; 2023 Jan; 73(726):e24-e33. PubMed ID: 36443066
[TBL] [Abstract][Full Text] [Related]
19. Anthropometric measures in cardiovascular disease prediction: comparison of laboratory-based versus non-laboratory-based model.
Dhana K; Ikram MA; Hofman A; Franco OH; Kavousi M
Heart; 2015 Mar; 101(5):377-83. PubMed ID: 25502814
[TBL] [Abstract][Full Text] [Related]
20. Prognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the world.
Joseph P; Yusuf S; Lee SF; Ibrahim Q; Teo K; Rangarajan S; Gupta R; Rosengren A; Lear SA; Avezum A; Lopez-Jaramillo P; Gulec S; Yusufali A; Chifamba J; Lanas F; Kumar R; Mohammadifard N; Mohan V; Mony P; Kruger A; Liu X; Guo B; Zhao W; Yang Y; Pillai R; Diaz R; Krishnapillai A; Iqbal R; Yusuf R; Szuba A; Anand SS;
Heart; 2018 Apr; 104(7):581-587. PubMed ID: 29066611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
